24,471 results
Search Results
102. PAPER STANDARD GAMBLE <sbt>A Paper-based Measure of Standard Gamble Utility for Current Health</sbt>.
- Author
-
Phillip L. Ross, Benjamin Littenberg, Paul Fearn, Peter T. Scardino, Pierre I. Karakiewicz, and Michael W. Kattan
- Subjects
CANCER patients ,PROSTATE cancer ,EXOCRINE glands ,MEDICAL records ,PATIENTS - Abstract
Objectives: To develop and validate a paper-based instrument that is simple to administer and produces a reliable estimate of patient standard gamble (SG) utilities for current health status. Methods: A 1-page paper questionnaire instrument, paper standard gamble (PSG), was designed to estimate SG utilities. We performed two studies to assess the validity of PSG. First we compared PSG and SG utilities for current health in patients with prostate cancer. They randomly received either PSG followed by SG or vice versa, always with an intervening SF-12. In the second validity study, we assessed the test-retest reliability of PSG by administering it to prostate cancer patients twice, at least 2 weeks apart. Results: In the first study, utilities were assessed in 64 men (32 per SG/PSG order group). A paired-comparison t test suggested no difference between SG and PSG (mean difference = -0.007; 95% confidence interval (CI), $-$0.022 to 0.008). The concordance correlation coefficient was 0.92 (95% CI, 0.79 to 0.99). In the second study, test and retest PSGs were available for 184 patients. The concordance correlation coefficient was 0.88 (95% CI, 0.73 to 0.94). Conclusions: These data suggest that PSG may serve as a reliable substitute for SG when current health utility is of interest. PSG may have particular advantages for acquisition of health-related quality-of-life data in longitudinal studies. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
103. Using Web-Based and Paper-Based Questionnaires for Collecting Data on Fertility Issues Among Female Childhood Cancer Survivors: Differences in Response Characteristics.
- Author
-
van den Berg, Marleen H., Overbeek, Annelies, van der Pal, Helena J., Versluys, A. Birgitta, Bresters, Dorine, van Leeuwen, Flora E., Lambalk, Cornelis B., Kaspers, Gertjan J. L., and van Dulmen-den Broeder, Eline
- Subjects
OLDER women ,WORLD Wide Web ,INTERNET ,CANCER patients ,PREMATURE ovarian failure ,STUDENTS - Abstract
Background: Web-based questionnaires have become increasingly popular in health research. However, reported response rates vary and response bias may be introduced. Objective: The aim of this study was to evaluate whether sending a mixed invitation (paper-based together with Web-based questionnaire) rather than a Web-only invitation (Web-based questionnaire only) results in higher response and participation rates for female childhood cancer survivors filling out a questionnaire on fertility issues. In addition, differences in type of response and characteristics of the responders and nonresponders were investigated. Moreover, factors influencing preferences for either the Web- or paper-based version of the questionnaire were examined. Methods: This study is part of a nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female childhood cancer survivors. The Web-based version of the questionnaire was available for participants through the Internet by means of a personalized user name and password. Participants were randomly selected to receive either a mixed invitation (paper-based questionnaire together with log-in details for Web-based questionnaire, n = 137) or a Web-only invitation (log-in details only, n = 140). Furthermore, the latter group could request a paper-based version of the questionnaire by filling out a form. Results: Overall response rates were comparable in both randomization groups (83% mixed invitation group vs 89% in Web-only invitation group, P =.20). In addition, participation rates appeared not to differ (66% or 90/137, mixed invitation group vs 59% or 83/140, Web-only invitation group, P =.27). However, in the mixed invitation group, significantly more respondents filled out the paper-based questionnaire compared with the Web-only invitation group (83% or 75/90 and 65% or 54/83, respectively, P =.01). The 44 women who filled out the Web-based version of the questionnaire had a higher educational level than the 129 women who filled out the paper-based version (P =.01). Furthermore, the probability of filling out the Web-based questionnaire appeared to be greater for women who were allocated to the Web-only invitation group (OR = 2.85, 95% CI 1.31 - 6.21), were older (OR = 1.08, 95% CI 1.02 - 1.15), had a higher educational level (OR high vs low = 0.06, 95% CI 0.01 - 0.52), or were students (OR employed vs student = 3.25, 95% CI 1.00 - 10.56). Conclusions: Although overall response as well as participation rates to both types of invitations were similar, adding a paper version of a questionnaire to a Web-only invitation resulted in more respondents filling out the paper-based version. In addition, women who were older, had a higher level of education, or were students, were more likely to have filled out the Web-based version of the questionnaire. Given the many advantages of Web-based over paper-based questionnaires, researchers should strongly consider using Web-based questionnaires, although possible response bias when using these types of questionnaires should be taken into account. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
104. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.
- Author
-
Mistry, Pankaj, Dunn, Janet A., and Marshall, Andrea
- Subjects
CANCER patients ,FOSTER home care ,MEDICAL care ,CLINICAL trials ,PUBLIC health ,EXPERIMENTAL design ,MEDICAL protocols ,ONCOLOGY ,SYSTEMATIC reviews ,STANDARDS - Abstract
Background: The application of adaptive design methodology within a clinical trial setting is becoming increasingly popular. However the application of these methods within trials is not being reported as adaptive designs hence making it more difficult to capture the emerging use of these designs. Within this review, we aim to understand how adaptive design methodology is being reported, whether these methods are explicitly stated as an 'adaptive design' or if it has to be inferred and to identify whether these methods are applied prospectively or concurrently.Methods: Three databases; Embase, Ovid and PubMed were chosen to conduct the literature search. The inclusion criteria for the review were phase II, phase III and phase II/III randomised controlled trials within the field of Oncology that published trial results in 2015. A variety of search terms related to adaptive designs were used.Results: A total of 734 results were identified, after screening 54 were eligible. Adaptive designs were more commonly applied in phase III confirmatory trials. The majority of the papers performed an interim analysis, which included some sort of stopping criteria. Additionally only two papers explicitly stated the term 'adaptive design' and therefore for most of the papers, it had to be inferred that adaptive methods was applied. Sixty-five applications of adaptive design methods were applied, from which the most common method was an adaptation using group sequential methods.Conclusions: This review indicated that the reporting of adaptive design methodology within clinical trials needs improving. The proposed extension to the current CONSORT 2010 guidelines could help capture adaptive design methods. Furthermore provide an essential aid to those involved with clinical trials. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
105. Position Paper Update.
- Subjects
EDUCATIONAL reports ,PERIODONTICS ,HIV-positive persons ,CANCER patients ,PIT & fissure sealants (Dentistry) ,WEBSITES ,DENTAL literature - Abstract
The article reports on position papers that were cancelled by the Board of Trustees of the American Academy of Periodontology (AAP) in May 2007. They include "Periodontal Considerations in the HIV Positive Patient," "Periodontal Considerations in the Management of the Cancer Patient" and "Sonic and Ultrasonic Sealers in Periodontics." It notes the removal of such papers from the Web site of the academy and sites of the "Journal of Periodontology." It encourages readers to refer to the literature for the latest information on those subjects.
- Published
- 2007
- Full Text
- View/download PDF
106. Letter to the editor regarding the paper by Loquai C et al. ‘Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients’.
- Author
-
Fabre, Elizabeth, Thomas-Schoemann, Audrey, and Blanchet, Benoit
- Subjects
- *
MELANOMA treatment , *CANCER patients , *ALTERNATIVE medicine , *MEDICAL cooperation , *RESEARCH , *CROSS-sectional method , *EDUCATION - Published
- 2017
- Full Text
- View/download PDF
107. Spontaneous Tumor Regression and Reversion: Insights and Associations with Reduced Dietary Phosphate.
- Author
-
Brown, Ronald B.
- Subjects
CANCER relapse ,FOOD consumption ,AUTOPHAGY ,PROTEIN kinases ,PHOSPHATES ,CELL proliferation ,CELL physiology ,DISEASE remission ,CANCER patients ,PHOSPHATASES ,CELL lines ,ANOREXIA nervosa ,WESTERN diet ,OVERALL survival - Abstract
Simple Summary: In spontaneous tumor regression, tumors shrink and disappear without conventional treatments. This phenomenon challenges the view that cancer is an irreversible genetic disease and that the only treatment option is to kill cancer cells or surgically remove them. In tumor reversion, cancer cells have been shown to return to normal cells when they are transplanted into a normal cellular environment. Additionally, people consuming a Western diet ingest excessive amounts of dietary phosphate, and a dysregulated oversupply of phosphate can be transported into cells, stimulating the cellular growth that forms tumors. Based on reviewed evidence, this paper proposes that reducing excessive dietary phosphate potentially activates tumor regression and reversion, as components of cancer cells are self-digested. Furthermore, fevers and fasting-mimicking diets are associated with tumor regression, which also may be initiated by reduced phosphate intake. Studies are needed to test dietary phosphate reduction in tumor regression and reversion to improve cancer patient survival. Tumors that spontaneously shrink from unknown causes in tumor regression, and that return to normal cells in tumor reversion, are phenomena with the potential to contribute new knowledge and novel therapies for cancer patient survival. Tumorigenesis is associated with dysregulated phosphate metabolism and an increased transport of phosphate into tumor cells, potentially mediated by phosphate overload from excessive dietary phosphate intake, a significant problem in Western societies. This paper proposes that reduced dietary phosphate overload and reregulated phosphate metabolism may reverse an imbalance of kinases and phosphatases in cell signaling and cellular proliferation, thereby activating autophagy in tumor regression and reversion. Dietary phosphate can also be reduced by sickness-associated anorexia, fasting-mimicking diets, and other diets low in phosphate, all of which have been associated with tumor regression. Tumor reversion has also been demonstrated by transplanting cancer cells into a healthy microenvironment, plausibly associated with normal cellular phosphate concentrations. Evidence also suggests that the sequestration and containment of excessive phosphate within encapsulated tumors is protective in cancer patients, preventing the release of potentially lethal amounts of phosphate into the general circulation. Reducing dietary phosphate overload has the potential to provide a novel, safe, and effective reversion therapy for cancer patients, and further research is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
108. The effects of oral nutritional supplements interventions on nutritional status in patients undergoing colorectal cancer surgery: A systematic review.
- Author
-
Qin, Xiaohong, Sun, Jiao, Liu, Meiling, Zhang, Lianjie, Yin, Qing, and Chen, Si
- Subjects
WEIGHT loss ,MEDICAL information storage & retrieval systems ,BODY mass index ,CINAHL database ,BODY weight ,ORAL drug administration ,COLORECTAL cancer ,EVALUATION of medical care ,META-analysis ,CANCER patients ,SYSTEMATIC reviews ,MEDLINE ,NUTRITIONAL status ,MEDICAL databases ,ONLINE information services ,DIETARY supplements ,GRIP strength ,SARCOPENIA - Abstract
Background: The high incidence of malnutrition in patients undergoing colorectal cancer surgery can lead to unplanned weight loss, sarcopenia and reduced grip strength to the extent that it can seriously affect the prognosis of colorectal cancer patients. Objective: This study investigated the effect of oral nutritional supplements (ONS) on the prevalence of grip strength, unplanned weight loss and sarcopenia in patients undergoing colorectal cancer surgery. Methods: We systematically searched randomized controlled studies from CINAHL, PubMed, Embase, Cochrane and Web of Science and three Chinese databases (CNKI, Wan‐Fang database, VIP database) from database creation to September 2023. The risk of bias in individual studies was assessed using the Cochrane Collaboration tool, and the certainty of evidence was assessed using the five GRADE criteria. Statistical analysis was performed using the RevMan 5.3 software, and information that could not be meta‐analysed was reviewed in the form of a literature summary. Results: Eleven papers met the inclusion criteria with a combined sample size of 1070 cases, including 532 cases in the trial group and 538 cases in the control group. Four papers reported the effect of ONS on grip strength and included very low‐quality evidence supporting no effect of ONS on grip strength. Ten studies reported the effect of ONS on body weight and body mass index (BMI) and included very low‐quality evidence supporting a positive ONS on weight and BMI changes. Meta‐analysis showed a significant reduction in weight loss (12–15 weeks) and BMI loss (12–15 weeks) in patients with colorectal cancer in the ONS group. The effect of ONS on the prevalence of sarcopenia after hospital discharge was reported in two studies, and meta‐analysis showed a significant reduction in the prevalence of postoperative sarcopenia in colorectal cancer patients in the ONS group, but the quality of evidence was low. Conclusions: This study showed that the use of ONS in patients undergoing surgery for colorectal cancer improved patient weight loss and BMI reduction and reduced the prevalence of postoperative sarcopenia but did not improve patient grip strength. The quality of evidence for inclusion in the article was low or very low, and further studies are needed to provide better evidence. Summary statement: What is already known about this topic? Some guidelines recommend the use of oral nutritional supplements in the perioperative and postoperative phases for patients with colorectal cancer.Previous studies have shown inconsistent results regarding the ability of oral nutritional supplements to improve weight and BMI and reduce the prevalence of sarcopenia in cancer patients. What this paper adds? For the first time, a systematic review was conducted using the malnutrition diagnostic criteria recommended by the Global Malnutrition Leadership Initiative consensus published in 2019, with unplanned weight loss, BMI change, prevalence of sarcopenia and grip strength as outcome indicators.Oral nutritional supplements reduce the prevalence of postoperative sarcopenia in patients with colorectal cancer but do not improve patients' grip strength. The implications of this paper: This study adds to the existing evidence for the use of oral nutritional supplements in perioperative and postoperative follow‐up periods for colorectal cancer.Nursing and other healthcare professionals should use evidence of the effectiveness of oral nutritional supplements to improve nutritional support for patients with colorectal cancer in the perioperative and postoperative periods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
109. Fatigue, sleep and physical activity in postoperative patients with pituitary adenomas: A survey.
- Author
-
She, Sunju, Wu, Yuping, Mu, Aiping, Cui, Feifei, Zhao, Xin, and Shen, Meifen
- Subjects
PEARSON correlation (Statistics) ,CROSS-sectional method ,EXERCISE ,SURGERY ,PATIENTS ,T-test (Statistics) ,DATA analysis ,QUESTIONNAIRES ,MULTIPLE regression analysis ,SEX distribution ,CANCER patients ,TERTIARY care ,HOSPITALS ,DESCRIPTIVE statistics ,SLEEP ,ONE-way analysis of variance ,STATISTICS ,CANCER fatigue ,POSTOPERATIVE period ,PITUITARY tumors ,DATA analysis software ,LENGTH of stay in hospitals ,SLEEP quality ,SLEEP disorders ,PHYSICAL activity ,REGRESSION analysis - Abstract
Background: The condition and correlation of fatigue, sleep and physical activity in postoperative patients with pituitary adenomas remain unclear. This survey aimed to evaluate the current status and influencing factors of fatigue, sleep and physical activity in postoperative patients with pituitary adenomas. Methods: Patients undergoing pituitary adenoma resection in two tertiary hospitals from November 2019 to November 2021 were included. The general data questionnaire, Multidimensional Fatigue Inventory (MFI‐20), Pittsburgh Sleep Quality Index (PSQI) and international physical activity questionnaire were used for data analysis. Results: In total, 184 patients with pituitary adenomas were included. The postoperative patients with pituitary adenomas had a high level of fatigue. In total, 34 (18.5%) patients had low level of physical activity, 76(41.3%) patients had medium level of physical activity and 74 (40.2%) had high level of physical activity. Postoperative time, PSQI, physical activity level and gender were the influencing factors of fatigue in patients with pituitary adenomas (all P < 0.05). Conclusions: Postoperative patients with pituitary adenomas have a higher level of fatigue, and it is related to reduced sleep quality and activity. Relevant nursing measures should be taken according to the influencing factors of fatigue to reduce the fatigue of postoperative patients with pituitary adenomas. Summary statement: What is already known about this topic? The postoperative nursing care of patients is very important to the quality of life in patients with pituitary adenomas.Fatigue, sleep and physical activity in postoperative patients with pituitary adenomas remain unclear. What this paper adds? There is a high level of fatigue in patients with pituitary adenomas within 1 year after operation.The degree of fatigue is negatively correlated with the course of disease and the level of physical activity. The implications of this paper: Interventions and nursing care strategies targeted on the factors affecting postoperative fatigue of patients with pituitary adenomas are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
110. Rákos betegek mentális és lelki kísérése.
- Author
-
Gyöngyi, BALOGH
- Subjects
SPIRITUALITY ,PSYCHOLOGICAL literature ,PASTORAL care ,DIGNITY ,CANCER patients ,QUALITY of life - Abstract
This paper explores the mental and spiritual accompaniment of cancer patients from a theological and pastoral perspective. The author reflects on her early experiences as a hospital chaplain and the challenges of communicating hope and comfort to patients facing a life-threatening diagnosis. She reviews the current literature on the psychological, social, and spiritual aspects of cancer and how they affect patients’ coping strategies, quality of life, and meaning making. She also discusses the role of the Church and its functionaries in providing support and guidance to cancer patients, as well as the potential benefits of what a theologically reflected service can offer in extension to other approaches. The paper emphasizes the importance of understanding the patients’ emotional, relational, and spiritual needs and of respecting their individuality and dignity. The paper also highlights the supreme relevance of the Christian faith as a source of hope for cancer patients. The paper concludes with some practical suggestions for pastoral care and spiritual accompaniment of cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
111. Langerhans Cells in Sentinel Lymph Nodes from Melanoma Patients.
- Author
-
Gerlini, Gianni, Susini, Pietro, Sestini, Serena, Brandani, Paola, Giannotti, Vanni, and Borgognoni, Lorenzo
- Subjects
EPITHELIAL cells ,MELANOMA ,SENTINEL lymph nodes ,IMMUNOTHERAPY ,CANCER patients ,DESCRIPTIVE statistics ,SYSTEMATIC reviews ,MEDLINE ,METASTASIS ,ONLINE information services ,QUALITY assurance ,DENDRITIC cells - Abstract
Simple Summary: Melanoma, the deadliest skin cancer, is a focus of research worldwide. This malignancy has been demonstrated to evade the immune system through several escape mechanisms. Among these, melanoma-related Dendritic Cells (DCs) alterations, particularly within the Sentinel Lymph Node (SLN), seem to play a key role. In SLNs, melanoma-related factors create a tumor microenvironment capable of impairing the immune response, inducing tolerance to tumor antigens and thus favoring SLN early metastases. The present literature review describes the interactions between Langerhans Cell (LC), a particular DC subset, and melanoma, suggesting a new potential therapeutic target. Background. Langerhans cells (LCs) are professional Dendritic Cells (DCs) involved in immunoregulatory functions. At the skin level, LCs are immature. In response to tissue injuries, they migrate to regional Lymph Nodes (LNs), reaching a full maturation state. Then, they become effective antigen-presenting cells (APCs) that induce anti-cancer responses. Notably, melanoma patients present several DC alterations in the Sentinel Lymph Node (SLN), where primary antitumoral immunity is generated. LCs are the most represented DCs subset in melanoma SLNs and are expected to play a key role in the anti-melanoma response. With this paper, we aim to review the current knowledge and future perspectives regarding LCs and melanoma. Methods. A systematic review was carried out according to the PRISMA statement using the PubMed (MEDLINE) library from January 2004 to January 2024, searching for original studies discussing LC in melanoma. Results. The final synthesis included 15 articles. Several papers revealed significant LCs–melanoma interactions. Conclusions. Melanoma immune escape mechanisms include SLN LC alterations, favoring LN metastasis arrival/homing and melanoma proliferation. The SLN LCs of melanoma patients are defective but not irreversibly, and their function may be restored by appropriate stimuli. Thus, LCs represent a promising target for future immunotherapeutic strategies and cancer vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
112. Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.
- Author
-
Rajan, Arun, Sivapiromrat, Alisa K., and McAdams, Meredith J.
- Subjects
COMBINATION drug therapy ,IMMUNOLOGICAL tolerance ,GENOMICS ,PATIENT safety ,THYMOMA ,IMMUNOTHERAPY ,CANCER patients ,TREATMENT effectiveness ,THYMUS tumors ,IMMUNE checkpoint inhibitors ,QUALITY of life ,SURVIVAL analysis (Biometry) ,QUALITY assurance ,BIOMARKERS ,EPITHELIAL cell tumors - Abstract
Simple Summary: Immune checkpoint inhibitors have revolutionized cancer therapy and improved clinical outcomes. Immunotherapy is now increasingly combined with chemotherapy and other conventional treatments, such as radiation therapy, as part of the multimodal treatment of earlier-stage cancers. Although generally well tolerated and capable of inducing long-lasting responses, immunotherapy for thymic epithelial tumors can be challenging due to defects in immune self-tolerance, which increase the risk of immune-mediated toxicity. In order to improve the safety of immunotherapy and maximize clinical benefit in patients with thymic cancers, there is a pressing need to identify potential biomarkers of response and toxicity for this patient population. In this paper, we review the current role of immunotherapy for thymic cancers and discuss future applications across the spectrum of stage and histology of these diseases. Thymic epithelial tumors are a histologically diverse group of cancers arising from the epithelial compartment of the thymus. These tumors are characterized by a low tumor mutation burden, a lack of actionable genomic changes, and, especially with thymomas, defects in immune tolerance. Surgery is the mainstay of the management of resectable disease, whereas advanced, unresectable tumors are treated with platinum-based chemotherapy. Disease recurrence can occur months to years after frontline treatment. Although several options are available for conventional treatment of recurrent thymic tumors, response rates are generally low, and treatment-related toxicity can affect quality of life. A subset of patients benefit from biologic therapies, but there remains an unmet need for the development of new treatments. Immune checkpoint inhibitors are safe, clinically active, and have contributed to an improvement in survival for patients with a wide variety of cancers. However, the application of these revolutionary treatments for thymic cancers is limited to their use for the management of recurrent thymic carcinoma because of the risk of immune toxicity. In this paper, we review the current uses of immunotherapy for the management of thymic epithelial tumors and highlight potential strategies to improve safety and broaden the application of these treatments for patients with thymic cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
113. Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
- Author
-
Jaromin, Maciej, Konecki, Tomasz, and Kutwin, Piotr
- Subjects
THERAPEUTIC use of antineoplastic agents ,NON-muscle invasive bladder cancer ,CONSERVATIVE treatment ,CYSTECTOMY ,CABAZITAXEL ,CISPLATIN ,BCG vaccines ,IMMUNOTHERAPY ,CANCER patients ,TREATMENT effectiveness ,DRUG delivery systems ,DRUG approval ,MONOCLONAL antibodies ,CANCER chemotherapy ,QUALITY of life ,GEMCITABINE ,WELL-being - Abstract
Simple Summary: Bladder cancer is a common disease in urological patients. The approach to treatment depends on the severity of the tumor; in this article, we focus on tumors that do not invade the muscle layer of the bladder. Those tumors are resected during an endoscopic procedure (TURBT), but often reoccur. Treating bladder cancer with drugs instead of surgical removal of the bladder (radical cystectomy) is paramount for patients quality of life and overall well-being. The aim of this paper is to review methods of conservative treatment of tumors unresponsive to the typical treatment of choice (BCG instillations). Bladder cancer is the 10th most popular cancer in the world, and non-muscle-invasive bladder cancer (NMIBC) is diagnosed in ~80% of all cases. Treatments for NMIBC include transurethral resection of the bladder tumor (TURBT) and intravesical instillations of Bacillus Calmette-Guérin (BCG). Treatment of BCG-unresponsive tumors is scarce and usually leads to Radical Cystectomy. In this paper, we review recent advancements in conservative treatment of BCG-unresponsive tumors. The main focus of the paper is FDA-approved medications: Pembrolizumab and Nadofaragene Firadenovec (Adstiladrin). Other, less researched therapeutic possibilities are also included, namely: N-803 immunotherapy, TAR-200 and TAR-210 intravesical delivery systems and combined Cabazitaxel, Gemcitabine and Cisplatin chemotherapy. Conservative treatment and delaying radical cystectomy would greatly benefit patients' quality of life; it is undoubtedly the future of BCG-unresponsive NMIBC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
114. New Breast Cancer Study Results from University Hospital of Caen Described (Tackling Insomnia Symptoms through Vestibular Stimulation in Patients with Breast Cancer: A Perspective Paper).
- Subjects
VESTIBULAR stimulation ,BREAST cancer ,UNIVERSITY hospitals ,CANCER patients ,SLEEP duration - Abstract
Keywords: Breast Cancer; Cancer; Circadian Rhythms; Drugs and Therapies; Health and Medicine; Oncology; Women's Health EN Breast Cancer Cancer Circadian Rhythms Drugs and Therapies Health and Medicine Oncology Women's Health 539 539 1 06/12/23 20230616 NES 230616 2023 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on breast cancer is the subject of a new report. Breast Cancer, Cancer, Circadian Rhythms, Drugs and Therapies, Health and Medicine, Oncology, Women's Health. [Extracted from the article]
- Published
- 2023
115. Social work in end-of-life care: A review of the most highly cited papers.
- Author
-
Henry, Blair, Lam, Michael, Chow, Ronald, Chiu, Leonard, Chow, Selina, Chow, Edward, Lam, Henry, Pulenzas, Natalie, and Lechner, Breanne
- Subjects
PAIN management ,CANCER patients ,ETHICS ,MEDICAL care ,MEDICAL quality control ,PATIENTS ,SOCIAL case work ,TERMINALLY ill - Abstract
Background: This study provides a bibliography on the topic of social work in end-of-life (EOL) care, based on the 50 most highly cited papers in this field as presented in the Scopus database. Method: A search was conducted in Scopus to determine the most frequently cited papers in the area of social work in EOL care. To limit the results to references highly relevant to social work, the phrases ‘social work' and ‘social worker' were searched as both subject and title keywords. The results were then combined with the subject keywords ‘end of life’, ‘palliative care’, ‘hospice care’, and ‘terminal care’. Results: A total of 193 references dating between 1987 and 2011 were found on social work in EOL care. Discussion: Literature on this topic is limited. A majority (68%) of the top 50 cited articles were published in a 6 year period between 2000 and 2006. A total of 14 journals were involved, with the Journal of Social Work in end-of-life and Palliative Care publishing the most articles on the list. The top articles were further reviewed with 15 key topics identified. [ABSTRACT FROM AUTHOR]
- Published
- 2015
116. Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club.
- Author
-
Gielen, E., Bergmann, P., Bruyère, O., Cavalier, E., Delanaye, P., Goemaere, S., Kaufman, J.-M., Locquet, M., Reginster, J.-Y., Rozenberg, S., Vandenbroucke, A.-M., Body, J.-J., and Bruyère, O
- Subjects
- *
EPIDEMIOLOGY , *OSTEOPOROSIS , *ANOREXIA nervosa , *CANCER patients , *DISEASES , *BONE fractures , *CONFERENCES & conventions - Abstract
In this consensus paper, the Belgian Bone Club aims to provide a state of the art on the epidemiology, diagnosis, and management of osteoporosis in frail individuals, including patients with anorexia nervosa, patients on dialysis, cancer patients, persons with sarcopenia, and the oldest old. All these conditions may indeed induce bone loss that is superimposed on physiological bone loss and often remains under-recognized and under-treated. This is of particular concern because of the major burden of osteoporotic fractures in terms of morbidity, mortality, and economic cost. Therefore, there is an urgent need to appreciate bone loss associated with these conditions, as this may improve diagnosis and management of bone loss and fracture risk in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
117. Towards conceptualizing patients as partners in health systems: a systematic review and descriptive synthesis.
- Author
-
Vanstone, Meredith, Canfield, Carolyn, Evans, Cara, Leslie, Myles, Levasseur, Mary Anne, MacNeil, Maggie, Pahwa, Manisha, Panday, Janelle, Rowland, Paula, Taneja, Shipra, Tripp, Laura, You, Jeonghwa, and Abelson, Julia
- Subjects
PATIENT participation ,CAREGIVERS ,HIGH-income countries ,CANCER patients - Abstract
Background: With the sharp increase in the involvement of patients (including family and informal caregivers) as active participants, collaborators, advisors and decision-makers in health systems, a new role has emerged: the patient partner. The role of patient partner differs from other forms of patient engagement in its longitudinal and bidirectional nature. This systematic review describes extant work on how patient partners are conceptualized and engaged in health systems. In doing so, it furthers the understanding of the role and activities of patient partners, and best practices for future patient partnership activities. Methods: A systematic review was conducted of peer-reviewed literature published in English or French that describes patient partner roles between 2000 and 2021 in any country or sector of the health system. We used a broad search strategy to capture descriptions of longitudinal patient engagement that may not have used words such as "partner" or "advisor". Results: A total of 506 eligible papers were identified, representing patient partnership activities in mostly high-income countries. These studies overwhelmingly described patient partnership in health research. We identified clusters of literature about patient partnership in cancer and mental health. The literature is saturated with single-site descriptive studies of patient partnership on individual projects or initiatives. There is a lack of work synthesizing impacts, facilitating factors and outcomes of patient partnership in healthcare. Conclusions: There is not yet a consolidated understanding of the role, activities or impacts of patient partners. Advancement of the literature has been stymied by a lack of consistently used terminology. The literature is ready to move beyond single-site descriptions, and synthesis of existing pockets of high-quality theoretical work will be essential to this evolution. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
118. Assessment of the quality of reporting in studies of acupuncture for patients with cancer using the STRICTA guidelines.
- Author
-
Hughes, John G, Lewith, George, MacPherson, Hugh, Witt, Claudia M, Cummings, Mike, and Fisher, Peter
- Subjects
ACUPUNCTURE ,CANCER patients ,CINAHL database ,CLINICAL trials ,INFORMATION storage & retrieval systems ,MEDICAL databases ,MEDLINE ,ONLINE information services ,REPORT writing ,ELECTRONIC publications ,SYSTEMATIC reviews - Abstract
Introduction: There has been a burgeoning of research evaluating acupuncture for various symptoms of cancer and the side-effects associated with its treatment. A systematic review was conducted to examine the quality of reporting in published studies of acupuncture in cancer according to the STRICTA (STandards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines. Methods: Systematic review of published research of acupuncture for symptoms of cancer and the side-effects associated with its treatment. Databases searched were: Medline, CINAHL, Cochrane (all databases), Scopus, and PubMed from their inception to December 2014. Clinical trials, pilot/feasibility studies, observational studies, and case studies were included. Only full journal papers published in English were included. The quality of reporting was evaluated using STRICTA guidelines. Each included paper was assessed by two independent reviewers, with disagreements adjudicated by a third reviewer. Results: 88 papers were identified which met the inclusion criteria. The median number of STRICTA items reported in trials with a control or comparator arm (n=47) was 14 out of 17 (range 8 to 17, IQR 4). For studies without a control or comparator arm the median was 11 out of a possible 15 (range 5 to 15, IQR 3). Key weaknesses in reporting included details of other components of treatments, and details of the acupuncturist administering treatments. Conclusions: Despite the widespread use of the STRICTA guidelines in acupuncture research, adherence remains poor for a few specific items. Further research is required to explore the reasons why authors fail to report those items, and to develop strategies to improve the adherence to the guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
119. Subtotal glossectomy preserving half the tongue base prevents taste disorder in patients with tongue cancer.
- Author
-
Tomita, S., Terao, Y., Hatano, T., and Nishimura, R.
- Subjects
TONGUE cancer ,CANCER patients ,TASTE disorders ,DEGLUTITION ,FILTER paper ,TUBE feeding ,DIAGNOSIS - Abstract
Most patients diagnosed with tongue carcinoma undergo surgical resection and reconstructive surgery to preserve tongue mobility and swallowing functions. Twenty-four patients who underwent a total or subtotal glossectomy and surgical reconstruction were evaluated for residual taste sensation. The graded filter paper test for all four tastes (sweet, salt, sour, and bitter) was performed on the posterior wall of the oropharynx and on tongue remnants if they were visible from the mouth. Eleven of the 24 patients were aware of their taste disorder after surgery. Four patients with more than 1/2 residual tongue base had no taste complaints, whereas seven of 14 patients with less than 1/3 residual tongue base reported taste abnormalities. Patients who could only tolerate a poor diet or tube feeding tended to have taste complaints (P=0.017). The taste test showed that the taste threshold of the residual tongue was significantly lower compared to controls. The taste threshold was significantly correlated with the remaining volume of tongue base. Patients with >1/2 the tongue base remaining had good taste sensation, whereas those with <1/3 residual tissue had impaired taste. This study suggests that glossectomy strategies aimed at preserving at least half the tongue base may substantially reduce dysgeusia in the patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
120. Paper predicts doubling of cancer patients
- Subjects
Medical research ,Medicine, Experimental ,Cancer patients - Abstract
Today in America, the likelihood of developing cancer during one's lifetime is approximately one in two for men and one in three for women. This staggering statistic, based on data [...]
- Published
- 2007
121. Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis
- Author
-
Eliza Działach, Joanna Huszno, Zofia Kołosza, Elżbieta Nowara, and Mateusz Grajek
- Subjects
Original Paper ,medicine.medical_specialty ,Chemotherapy ,Combination therapy ,business.industry ,Medical record ,medicine.medical_treatment ,COVID-19 ,Cancer ,Immunotherapy ,medicine.disease ,Systemic therapy ,cancer treatment ,Community hospital ,systemic therapy ,Oncology ,Internal medicine ,Case fatality rate ,Medicine ,Radiology, Nuclear Medicine and imaging ,cancer patients ,business ,coronavirus pandemic - Abstract
Introduction Patients with cancer undergoing active systemic anticancer treatment (chemotherapy, immunotherapy, targeted, or combination therapy) are at greater risk of COVID-19 infection than persons without cancer. In this paper, the authors analyse the spread of the coronavirus among cancer patients undergoing systemic therapy, and the impact of COVID-19 infection on the continuation of cancer treatment and its outcome at one community hospital in a mid-sized city in the south of Poland. Material and methods Nasopharyngeal swab was the only collection method used to obtain specimens for testing via real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Only those with positive RT-PCR results were considered as confirmed SARS-CoV-2 cases. We analysed the medical records of patients quarantined in a hospital clinical oncology ward due to confirmed COVID-19 infection in one member of the group. Qualitative measures are presented as the percentage of their occurrence, and these were evaluated with Fisher’s test. Differences were considered significant at p < 0.05. Results Cancer patients had more frequent confirmed COVID-19 infection than other patients (3.7% vs. 1.2%). Among cancer patients COVID-19 infection was significantly more frequent in women than in men, p = 0.005. The fatality rate was 27.3% in cancer patients undergoing active anticancer therapy, compared to 3% in the general Polish population. Neither heparin nor G-CSF use had any influence on COVID-19 infection. Conclusions In this analysis, the only significant negative factor for COVID-19 infection was female sex, RR (95% CI) = 4.5 (1.3–15.8), (p = 0.005), and this was attributable to individual behaviour.
- Published
- 2021
122. A systematic review of risk factors associated with depression and anxiety in cancer patients.
- Author
-
Ikhile, Deborah, Ford, Elizabeth, Glass, Devyn, Gremesty, Georgie, and van Marwijk, Harm
- Subjects
CANCER patients ,ANXIETY ,MENTAL depression ,LONG-term health care ,BIOPSYCHOSOCIAL model - Abstract
Depression and anxiety are common comorbid conditions associated with cancer, however the risk factors responsible for the onset of depression and anxiety in cancer patients are not fully understood. Also, there is little clarity on how these factors may vary across the cancer phases: diagnosis, treatment and depression. We aimed to systematically understand and synthesise the risk factors associated with depression and anxiety during cancer diagnosis, treatment and survivorship. We focused our review on primary and community settings as these are likely settings where longer term cancer care is provided. We conducted a systematic search on PubMed, PsychInfo, Scopus, and EThOS following the PRISMA guidelines. We included cross-sectional and longitudinal studies which assessed the risk factors for depression and anxiety in adult cancer patients. Quality assessment was undertaken using the Newcastle-Ottawa assessment checklists. The quality of each study was further rated using the Agency for Healthcare Research and Quality Standards. Our search yielded 2645 papers, 21 of these were eligible for inclusion. Studies were heterogenous in terms of their characteristics, risk factors and outcomes measured. A total of 32 risk factors were associated with depression and anxiety. We clustered these risk factors into four domains using an expanded biopsychosocial model of health: cancer-specific, biological, psychological and social risk factors. The cancer-specific risk factors domain was associated with the diagnosis, treatment and survivorship phases. Multifactorial risk factors are associated with the onset of depression and anxiety in cancer patients. These risk factors vary across cancer journey and depend on factors such as type of cancer and individual profile of the patients. Our findings have potential applications for risk stratification in primary care and highlight the need for a personalised approach to psychological care provision, as part of cancer care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
123. QNetDiff: a quantitative measurement of network rewiring.
- Author
-
Nose, Shota, Shiroma, Hirotsugu, Yamada, Takuji, and Uno, Yushi
- Subjects
LARGE intestine ,COLORECTAL cancer ,HUMAN body ,CANCER patients - Abstract
Bacteria in the human body, particularly in the large intestine, are known to be associated with various diseases. To identify disease-associated bacteria (markers), a typical method is to statistically compare the relative abundance of bacteria between healthy subjects and diseased patients. However, since bacteria do not necessarily cause diseases in isolation, it is also important to focus on the interactions and relationships among bacteria when examining their association with diseases. In fact, although there are common approaches to represent and analyze bacterial interaction relationships as networks, there are limited methods to find bacteria associated with diseases through network-driven analysis. In this paper, we focus on rewiring of the bacterial network and propose a new method for quantifying the rewiring. We then apply the proposed method to a group of colorectal cancer patients. We show that it can identify and detect bacteria that cannot be detected by conventional methods such as abundance comparison. Furthermore, the proposed method is implemented as a general-purpose tool and made available to the general public. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
124. Probiotics - when and for whom in the oncological patient population.
- Author
-
Łoniewski, Igor, Kaźmierczak-Siedlecka, Karolina, Komorniak, Natalia, and Stachowska, Ewa
- Subjects
CANCER patients ,PROBIOTICS ,GUT microbiome ,HUMAN microbiota ,BODY fluids - Abstract
The human microbiome contains trillions of microorganisms. These organisms vary from person to person like fingerprints, and their composition depends on both host and environmental factors, of which diet plays a crucial role. Knowledge of the human microbiome is possible thanks to the introduction of new DNA sequencing methods, which have been developed over the last decade (Human Microbiome Project). This is when the notion of dysbiosis, which is not quite correct, was coined, i.e. disruption of the normal human microbiota. In the absence of standards for the composition and function of the microbiome, dysbiosis is a conventional term describing the differences in the composition and function of the microbiome between a healthy population and a population affected by, for example, a disease; despite its imperfections, this definition is quite suitable for describing changes in the microbiome in the case of various diseases, including cancer. The microbiome can influence the development and course of cancer through direct oncogenic effects, pro-inflammatory effects on mucous membranes, generation of metabolic abnormalities, modulation of the immune response and efficacy of anticancer treatment. Both tumour tissue and neighbouring tissues contain their own microbiome, and the same applies to other tissues and body fluids, which, through the microbiome and its metabolites, antigens, etc., can influence tumour development, progression and response to treatment. The gut microbiome is an important regulator of the immune response. It can also influence tumours and their treatment in distant organs. Due to the link between the microbiome and cancer, the potential of its modification in oncological treatment is of great interest to researchers and clinicians. The aim of this paper is to present the current state of knowledge of one of the most popular methods of modifying the microbiome-probiotics, which are commonly used by oncology patients. The safety aspects of the use of probiotics and current meta-analyses on this group of products are mainly discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
125. Services, models of care, and interventions to improve access to cancer treatment for adults who are socially disadvantaged: A scoping review protocol.
- Author
-
Horrill, Tara C., Bourgeois, Amber, Kleijberg, Max, Linton, Janice, Leahy, Kate, and Stajduhar, Kelli I.
- Subjects
SOCIAL marginality ,CANCER treatment ,CANCER patients ,ACADEMIC librarians ,SOCIAL determinants of health - Abstract
Timely access to guideline-recommended cancer treatment is known to be an indicator of the quality and accessibility of a cancer care system. Yet people who are socially disadvantaged experience inequities in access to cancer treatment that have significant impacts on cancer outcomes and quality of life. Among people experiencing the intersecting impacts of poor access to the social determinants of health and personal identities typically marginalized from society ('social disadvantage'), there are significant barriers to accessing cancer, many of which compound one another, making cancer treatment extremely difficult to access. Although some research has focused on barriers to accessing cancer treatment among people who are socially disadvantaged, it is not entirely clear what, if anything, is being done to mitigate these barriers and improve access to care. Increasingly, there is a need to design cancer treatment services and models of care that are flexible, tailored to meet the needs of patients, and innovative in reaching out to socially disadvantaged groups. In this paper, we report the protocol for a planned scoping review which aims to answer the following question: What services, models of care, or interventions have been developed to improve access to or receipt of cancer treatment for adults who are socially disadvantaged? Based on the methodological framework of Arksey and O'Malley, this scoping review is planned in six iterative stages. A comprehensive search strategy will be developed by an academic librarian. OVID Medline, EMBASE, CINAHL (using EBSCOhost) and Scopus will be searched for peer-reviewed published literature; advanced searches in Google will be done to identify relevant online grey literature reports. Descriptive and thematic analysis methods will be used to analyze extracted data. Findings will provide a better understanding of the range and nature of strategies developed to mitigate barriers to accessing cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
126. Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape.
- Author
-
Jackson, Emily B., Curry, Lauren, Mariano, Caroline, Hsu, Tina, Cook, Sarah, Pezo, Rossanna C., Savard, Marie-France, Desautels, Danielle N., Leblanc, Dominique, and Gelmon, Karen A.
- Subjects
METASTATIC breast cancer ,OLDER people ,CANCER patients ,MEDICAL personnel ,BREAST cancer - Abstract
The prevalence of breast cancer amongst older adults in Canada is increasing. This patient population faces unique challenges in the management of breast cancer, as older adults often have distinct biological, psychosocial, and treatment-related considerations. This paper presents an expert consensus of the Canadian treatment landscape, focusing on key considerations for optimizing selection of systemic therapy for advanced breast cancer in older adults. This paper aims to provide evidence-based recommendations and practical guidance for healthcare professionals involved in the care of older adults with breast cancer. By recognizing and addressing the specific needs of older adults, healthcare providers can optimize treatment outcomes and improve the overall quality of care for this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
127. Paper reveals secrets of a cancer virus
- Subjects
Communicable diseases ,Virology ,Cancer patients ,Virus diseases ,Cancer ,Health ,Pharmaceuticals and cosmetics industries - Abstract
2003 AUG 15 - (NewsRx.com & NewsRx.net) -- Cancer Research UK scientists have revealed one of the cancer-causing secrets of the notorious Epstein-Barr Virus (EBV). Researchers in Manchester have discovered [...]
- Published
- 2003
128. Paper reveals secrets of a cancer virus
- Subjects
Communicable diseases ,Virology ,Cancer patients ,Virus diseases ,Cancer ,Biotechnology industry ,Pharmaceuticals and cosmetics industries - Abstract
2003 AUG 13 - (NewsRx.com & NewsRx.net) -- Cancer Research UK scientists have revealed one of the cancer-causing secrets of the notorious Epstein-Barr Virus (EBV). Researchers in Manchester have discovered [...]
- Published
- 2003
129. Paper reveals secrets of a cancer virus
- Subjects
Virology ,Communicable diseases ,Cancer patients ,Cancer ,Virus diseases ,Biotechnology industry ,Business - Abstract
2003 AUG 11 - (NewsRx.com & NewsRx.net) -- Cancer Research UK scientists have revealed one of the cancer-causing secrets of the notorious Epstein-Barr Virus (EBV). Researchers in Manchester have discovered [...]
- Published
- 2003
130. 'I think both of us drew strength from it': qualitative reflections from next of kin following the death and post-mortem brain donation of a loved one with brain cancer.
- Author
-
Griffin, Cassandra P., Carlson, Melissa A., Walker, Marjorie M., Lynam, James, and Paul, Christine L.
- Subjects
BRAIN physiology ,ATTITUDES toward death ,ALTRUISM ,DEATH ,AUTOPSY ,QUALITATIVE research ,GLIOMAS ,SELF-efficacy ,RESEARCH funding ,EVALUATION of human services programs ,INTERVIEWING ,FAMILIES ,ORGAN donation ,CANCER patients ,DESCRIPTIVE statistics ,THEMATIC analysis ,EXPERIENCE ,RESEARCH methodology ,PSYCHOLOGY of caregivers ,PHENOMENOLOGY ,BRAIN tumors - Abstract
Background: Glioblastoma, a high-grade primary brain cancer, has a median survival of approximately 14 months. Post-mortem brain donation provides insight to pathogenesis along with spatial and temporal heterogeneity. Post-mortem brain biobanking programs are increasing in number and the need to understand and improve the associated human experience is pressing. This study aims to qualitatively explore the experiences of next of kin (NOK) following the death and brain donation of a loved one and to understand the impact such programs have on NOK carers. Method: We interviewed 29 NOK following the death of their loved one and subsequent brain donation. Thematic analysis was conducted on the transcribed, qualitative interviews. Results: Four themes were identified; (1) Brain donation is a straightforward decision grounded in altruism and pragmatism; (2) Supporting donors is a source of comfort, pride and empowerment; (3) Brain donation can provide meaning for suffering and tragedy and (4) Perceptions of procedures and processes when supporting a loved one to donate. Insights into areas for improvement, for example transporting donors following a home death and the role of the body bag were also noted. Conclusion: Supporting a loved one to donate their brain can be a positive experience providing a source of hope, empowerment and purpose for NOK. Data indicating areas for consideration are broadly relevant for improving the delivery of brain donation programs for future donors and their loved ones. Plain language summary: Understanding how loved ones feel about someone close to them donating their brain to research after their death from brain cancer The act of donating brain tissue after death from brain cancer is a huge gift to medical research and may have an impact on the ability of the scientific community to improve outcomes for people diagnosed with brain cancers. While we understand how valuable these donations are for research, we need more work to understand how these donations impact the people who donate and those who love and support them. This paper explores the experiences of people who have lost someone to brain cancer who then went on to donate their brain tissue after their death. Through the use of interviews, it explores the impact that the donation has on a loved one or next of kin from providing a source of comfort, empowerment, pride or an alternative to 'senseless' suffering and tragedy. It also provides areas that should be considered by people who are facilitating brain donations to ensure that any potential, harm or upset can be minimized. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
131. Non-invasive technology to assess hydration status in advanced cancer to explore relationships between fluid status and symptoms: an observational study using bioelectrical impedance analysis.
- Author
-
Nwosu, Amara Callistus, Stanley, Sarah, Mayland, Catriona R, Mason, Stephen, McDougall, Alexandra, and Ellershaw, John E
- Subjects
STATISTICAL models ,DRINKING (Physiology) ,CANCER treatment ,MEDICAL technology ,RESEARCH funding ,SCIENTIFIC observation ,PILOT projects ,BODY composition ,MEDICAL care ,BIOELECTRIC impedance ,DECISION making ,CANCER patients ,DESCRIPTIVE statistics ,EVALUATION of medical care ,HYDRATION ,LONGITUDINAL method ,WATER in the body ,QUALITY of life ,TUMOR classification ,TUMORS ,TERMINAL care ,COMPARATIVE studies ,DEHYDRATION ,REGRESSION analysis ,SPECIALTY hospitals ,DISEASE complications - Abstract
Background: Oral fluid intake decreases in advanced cancer in the dying phase of illness. There is inadequate evidence to support the assessment, and management, of hydration in the dying. Bioelectrical impedance analysis (BIA) is a body composition assessment tool. BIA has the potential to inform clinal management in advanced cancer, by examining the relationships between hydration status and clinical variables. Aim: BIA was used to determine the association between hydration status, symptoms, clinical signs, quality-of-life and survival in advanced cancer, including those who are dying (i.e. in the last week of life). Materials and methods: We conducted a prospective observational study of people with advanced cancer in three centres. Advance consent methodology was used to conduct hydration assessments in the dying. Total body water was estimated using the BIA Impedance index (Height – H (m)
2 /Resistance – R (Ohms)). Backward regression was used to identify factors (physical signs, symptoms, quality of life) that predicted H2 /R. Participants in the last 7 days of life were further assessed with BIA to assess hydration changes, and its relationship with clinical outcomes. Results: One hundred and twenty-five people participated (males n = 74 (59.2%), females, n = 51 (40.8%)). We used backward regression analysis to describe a statistical model to predict hydration status in advanced cancer. The model demonstrated that 'less hydration' (lower H2 /R) was associated with female sex (Beta = -0.39, p < 0.001), increased appetite (Beta = -0.12, p = 0.09), increased dehydration assessment scale score (dry mouth, dry axilla, sunken eyes - Beta = -0.19, p = 0.006), and increased breathlessness (Beta = -0.15, p = 0.03). 'More hydration' (higher H2 /R) was associated with oedema (Beta = 0.49, p < 0.001). In dying participants (n = 18, 14.4%), hydration status (H2 /R) was not significantly different compared to their baseline measurements (n = 18, M = 49.6, SD = 16.0 vs. M = 51.0, SD = 12.1; t(17) = 0.64, p = 0.53) and was not significantly associated with agitation (rs = -0.85, p = 0.74), pain (rs = 0.31, p = 0.23) or respiratory tract secretions (rs = -0.34, p = 0.19). Conclusions: This is the first study to use bioimpedance to report a model (using clinical factors) to predict hydration status in advanced cancer. Our data demonstrates the feasibility of using an advance consent method to conduct research in dying people. This method can potentially improve the evidence base (and hence, quality of care) for the dying. Future BIA research can involve hydration assessment of cancers (according to type and stage) and associated variables (e.g., stage of illness, ethnicity and gender). Further work can use BIA to identify clinically relevant outcomes for hydration studies and establish a core outcome set to evaluate how hydration affects symptoms and quality-of-life in cancer. Key message: What is already known about this topic? - Oral fluid intake decreases in people with advanced cancer, especially when they approach the dying phase of their illness. - There is inadequate evidence to support hydration assessment and decision making in the dying phase of illness. - It is important to understand which clinical factors are associated with hydration status in advanced cancer, to enable healthcare professionals, to evaluate hydration status and support clinical decision making. - Bioimpedance is a non-invasive technology, which has potential to identify clinically relevant variables for cancer hydration assessment. What this paper adds. - This is the first study to use bioimpedance to report a model (using clinical factors) to predict hydration status in advanced cancer. - The variables with combined significance for predicting hydration status were biological sex, appetite, dry mouth, dry axilla, sunken eyes, breathlessness and oedema. In the dying phase, hydration status did not significantly change compared to baseline, and hydration status was not significantly associated with survival. Implications for practice, theory or policy. - Further work can use bioimpedance to identify clinically relevant outcomes for hydration studies, to establish a core outcome set to evaluate how hydration affects symptoms and quality-of-life in cancer. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
132. From Pixels to Prognosis: A Survey on AI-Driven Cancer Patient Survival Prediction Using Digital Histology Images.
- Author
-
Parvaiz, Arshi, Nasir, Esha Sadia, and Fraz, Muhammad Moazam
- Subjects
CANCER relapse ,PREDICTION models ,ARTIFICIAL intelligence ,DIGITAL diagnostic imaging ,CANCER patients ,MEDICAL research ,CANCER patient psychology ,SURVIVAL analysis (Biometry) ,TUMORS ,INDIVIDUALIZED medicine ,ONCOLOGISTS ,MEDICAL practice - Abstract
Survival analysis is an integral part of medical statistics that is extensively utilized to establish prognostic indices for mortality or disease recurrence, assess treatment efficacy, and tailor effective treatment plans. The identification of prognostic biomarkers capable of predicting patient survival is a primary objective in the field of cancer research. With the recent integration of digital histology images into routine clinical practice, a plethora of Artificial Intelligence (AI)-based methods for digital pathology has emerged in scholarly literature, facilitating patient survival prediction. These methods have demonstrated remarkable proficiency in analyzing and interpreting whole slide images, yielding results comparable to those of expert pathologists. The complexity of AI-driven techniques is magnified by the distinctive characteristics of digital histology images, including their gigapixel size and diverse tissue appearances. Consequently, advanced patch-based methods are employed to effectively extract features that correlate with patient survival. These computational methods significantly enhance survival prediction accuracy and augment prognostic capabilities in cancer patients. The review discusses the methodologies employed in the literature, their performance metrics, ongoing challenges, and potential solutions for future advancements. This paper explains survival analysis and feature extraction methods for analyzing cancer patients. It also compiles essential acronyms related to cancer precision medicine. Furthermore, it is noteworthy that this is the inaugural review paper in the field. The target audience for this interdisciplinary review comprises AI practitioners, medical statisticians, and progressive oncologists who are enthusiastic about translating AI-driven solutions into clinical practice. We expect this comprehensive review article to guide future research directions in the field of cancer research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
133. Tools to measure the burden on informal caregivers of cancer patients: A literature review.
- Author
-
Zhong, Mingming, Sun, Shanshan, Long, Jianying, Yuan, Mengyuan, Wang, Min, and Zhang, Zhigang
- Subjects
MEDICAL information storage & retrieval systems ,HEALTH status indicators ,MENTAL health ,CINAHL database ,RESEARCH evaluation ,CANCER patients ,EMOTIONS ,PATIENT care ,BURDEN of care ,SYSTEMATIC reviews ,MEDLINE ,PSYCHOMETRICS ,PSYCHOLOGY of caregivers ,ONLINE information services ,ACTIVITIES of daily living - Abstract
Objectives: (1) To describe existing tools to assess the burden of informal caregivers of people with cancer, (2) to describe how these tools have been validated and (3) to describe the areas of interest of existing assessment tool entries. Background: The caregiver burden of informal caregivers of people with cancer greatly affects their lives. There is a wide variety of relevant assessment tools available, but there are no studies to help researchers to select tools. Methods: A search was conducted using the keywords 'cancer', 'caregiver', 'burden' and 'scale' in Medline (PubMed), CINAHL and EMBASE to include articles that developed or applied tools to assess the burden on informal caregivers of cancer patients. Once eligible tools were identified, we searched their 'primary reference' studies. If the original scale was assessed in a population other than informal caregivers of cancer patients, we again searched for psychometric measures in the population of caregivers of cancer patients. Results: This study retrieved 938 articles on developing or applying the informal caregiver burden instrument for cancer patients, including 42 scales. Internal consistency of the original scales ranged from 0.53 to 0.96. Nineteen scales initially developed to assess caregiver burden for patients with dementia, stroke and other disorders were later used for caregivers of cancer patients, eight of which have not yet been validated. Reclassifying all scale domains of concern revealed that scale assessments focused more on caregivers' physical health, emotional state and caregiving tasks. Conclusion: This review identifies many scales for assessing informal caregiver burden in cancer patients and gives scales recommended. However, a portion still needs to be validated. The development of a new scale proposes to be based on a theoretical framework and to consider dimensions for assessing support resources. Impact: What problem did the study address?: This paper collates assessment tools on the burden of informal carers of people with cancer. It also provides information on the applicable population, reliability and validity. What were the main findings?: 41 scales could be considered for use, eight of which have not been validated. The scales focus more on assessing caregivers' physical health, emotional state and caregiving tasks, and less on the dimension of support resources. Where and on whom will the research have an impact?: There are implications for informal carers of cancer patients in hospitals or in the community, as well as for relevant researchers. Reporting Method: Retrieved with reference to systematic evaluation. Patient or Public Contribution: No patient or public contribution. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
134. Disentangling the value equation: a step forward in value-based healthcare.
- Author
-
García-Lorenzo, Borja, Alayo, Itxaso, Arrospide, Arantzazu, Gorostiza, Ania, Fullaondo, Ane, and Group, VOICE Study
- Subjects
SECONDARY analysis ,RESEARCH funding ,VALUE-based healthcare ,BREAST tumors ,BENCHMARKING (Management) ,CANCER patients ,EMOTIONS ,FUNCTIONAL status ,DESCRIPTIVE statistics ,PATIENT-centered care ,LUNG tumors ,PAIN ,QUALITY of life ,HEALTH outcome assessment ,SOCIODEMOGRAPHIC factors ,REGRESSION analysis - Abstract
Background The value equation of value-based healthcare (VBHC) as a single figure remains ambiguous, closer to a theoretical framework than a useful tool for decision making. The challenge lies in the way patient-centred outcomes (PCOs) might be combined to produce a single value of the numerator. This paper aims to estimate the weights of PCOs to provide a single figure in the numerator, which ultimately will allow a VBHC figure to be reached. Methods A cohort of patients diagnosed with breast cancer (n = 690) with a 6-month follow-up recruited in 2019–20 across six European hospitals was used. Patient-reported outcomes (PROs), clinical-related outcomes (CROs), and clinical and socio-demographic variables were collected. The numerator was defined as a composite indicator of the PCOs (CI-PCO), and regression analysis was applied to estimate their weights and consequently arrive at a single figure. Results Pain showed as the highest weight followed by physical functioning , emotional functioning , and ability to work , and then by a symptom, either arm or breast. PCOs weights were robust to sensitivity analysis. The CI-PCO value was found to be more informative than the health-related quality of life (HRQoL) value. Conclusions To the best of our knowledge, this is the first research to combine the PCOs proposed by ICHOM to provide a single figure in the numerator of the value equation. This figure shows a step forward in VBHC to reach a holistic benchmarking across healthcare centres and a value-based payment. This research might also be applied in other medical conditions as a methodological pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
135. The Ethical Complexity of Medical Decision Making in the Adolescent Oncology Patient.
- Author
-
Nash, Ariel Paige, Harden, Avis, and Sheth, Rachna Kalapi
- Subjects
MEDICAL decision making ,YOUNG adults ,AGE groups ,PEDIATRIC oncology ,CANCER patients - Abstract
Adolescent Medical Decision Making (aMDM) is frequently discussed but presents a significant challenge in practice, especially in cases of adolescents with life threatening or life limiting illnesses. In this paper, we present a case that explores the importance of aMDM, the difficulties for providers when engaging adolescents in these discussions, and how certain skills may be incorporated into pediatric practice. Literature suggests that patients of this age group, while being legally without capacity, have meaningful insights into their care. However, unless physicians feel comfortable and competent engaging adolescents in a manner that honors their developmentally appropriate understanding of their illness, these insights can be lost. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
136. Is three-dimensional ultrasonography a valuable diagnostic tool for patients with ovarian cancer? Systematic review and meta-analysis.
- Author
-
Yuan Liu, Qingdong Zhang, Fang Zhang, Meiyan Liu, Jun Zhang, Xiaoli Cao, and Weihong Yin
- Subjects
DIAGNOSTIC ultrasonic imaging ,OVARIAN cancer ,RECEIVER operating characteristic curves ,CANCER patients ,DOPPLER ultrasonography - Abstract
Introduction: This paper was to assess the diagnostic performance and clinical value of three-dimensional ultrasonography (3DUS), three-dimensional ultrasonography power Doppler (3DPD), and 3DUS combined with 3DPD in ovarian cancer (OC). Methods: The study was registered with PROSPERO (CRD 42023405765). PubMed and Web of Science were searched from inception to 25 January 2022, and reference lists of potentially eligible studies were also manually searched. Patient and study characteristics were extracted by two independent reviewers. Any discrepancies were addressed through discussion. The sensitivity, specificity, positive and negative likelihood ratio (PLR and NLR, respectively), and the area under the receiver operating characteristic curve (AUC) were pooled separately. Results: We retrieved 2,566 studies, of which 18 were finally enrolled, with 2,548 cases. The pooled sensitivity, specificity, PLR, NLR, and AUC for 3DUS were 0.89 (95% CI: 0.85-0.93), 0.93 (95% CI: 0.88-0.96), 13.1 (95% CI: 7.3-23.4), 0.11 (95% CI: 0.08-0.16), and 0.90 (95% CI: 0.87-0.93), respectively. The pooled sensitivity, specificity, PLR, NLR, and AUC for 3DPD were 0.90 (95% CI: 0.80-0.95), 0.85 (95% CI: 0.71-0.92), 5.8 (95% CI: 3.0-11.2), 0.12 (95% CI: 0.06-0.24), and 0.94 (95% CI: 0.91-0.96), respectively. The pooled sensitivity, specificity, PLR, NLR, and AUC for 3DUS combined with 3DPD were 0.99 (95% CI: 0.73-1.00), 0.95 (95% CI: 0.85-0.99), 21.9 (95% CI: 6.1-78.9), 0.01 (95% CI: 0.00-0.37), and 0.99 (95% CI: 0.98-1.00), respectively. Conclusions: 3DUS, 3DPD, and 3DUS combined with 3DPD are promising diagnostic tools for OC, alongside elevated sensitivity and specificity. However, the combination of 3DUS and 3DPD techniques has higher diagnostic efficiency. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD 42023405765. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
137. A nationwide neurosurgical inter-disciplinary service for cancer-related refractory pain.
- Author
-
khashan, Morsi, Strauss, Ido, Hochberg, Yehonathan, Brill, Silviu, Tellem, Rotem, Sharon, Haggai, and Hochberg, Uri
- Subjects
CANCER treatment ,NEUROSURGERY ,ABLATION techniques ,INTERPROFESSIONAL relations ,RETROSPECTIVE studies ,CANCER patients ,DESCRIPTIVE statistics ,CANCER pain ,OPERATIVE surgery ,PAIN management ,MEDICAL records ,ACQUISITION of data ,HEALTH care teams ,SPECIALTY hospitals - Abstract
Purpose: Neurosurgical ablative procedures, such as cordotomy and cingulotomy, are often considered irreversible and destructive but can provide an effective and individualized solution for cancer-related refractory pain, when all other approaches have been unsuccessful. This paper provides an in-depth exploration of a novel approach to managing refractory cancer pain. It involves an interdisciplinary team led by a neurosurgeon at a renowned national referral center. Methods: a retrospective analysis of the medical records of all sequential patients who underwent their initial evaluation at our interdisciplinary refractory cancer pain clinic from February 2017 to January 2023. Results: A total of 207 patients were examined in the clinic for a first visit during the study period. All patients were referred to the clinic due to severe pain that was deemed refractory by the referring physician. The mean age was 61 ± 12.3 years, with no significant sex difference (P = 0.58). The mean ECOG Performance Status score was 2.35. Conservative measures had not yet been exhausted in 28 patients (14%) and 9 patients were well controlled (4%). Neurosurgical ablative procedures were recommended for 151 (73%) of the patients. Sixty-six patients (32%) eventually underwent the procedure. 91 patients (44%) received a negative recommendation for surgery. Thirty-five patients (17%) were referred for further invasive procedures at the pain clinic. Conclusion: An Interdisciplinary cooperation between palliative care specialists, pain specialists, and neurosurgeons ensures optimal patient selection and provides safe and effective neurosurgery for the treatment of refractory cancer-related pain. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
138. Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence.
- Author
-
Siyu Wang, Shaoxuan Liu, Fangyuan Liu, Ying Guo, and Fengjuan Han
- Subjects
CANCER patients ,HYPERTHERMIC intraperitoneal chemotherapy ,PROGNOSIS ,OVERALL survival ,PROGRESSION-free survival - Abstract
Background: The newest clinical evidence that the relationship between the peritoneal cancer index (PCI) and the postoperative prognosis of advanced ovarian cancer patients remains controversial, and there are no large-sample and multicenter studies to clarify this matter. Therefore, in this paper, we used meta-analysis to systematically assess the postoperative prognostic value of PCI in subjects with advanced ovarian cancer to provide individualized treatment plans and thus improve the prognosis of patients. Methods: Literature on the correlation between PCI and the postoperative prognosis in subjects with advanced OC undergoing cytoreductive surgery (CRS) was searched in the Cochrane Library, Pubmed, Embase, and Web of Science from the database inception to April 20, 2023. The search was updated on February 28, 2024. We only included late-stage (FIGO stage: III-IV) patients who did not undergo neoadjuvant chemotherapy (NACT) or hyperthermic intraperitoneal chemotherapy (HIPEC). Afterwards, literature screening and data extraction were conducted using Endnote20 software. The literature quality was assessed using the Newcastle-Ottawa Scale (NOS). Lastly, statistical analysis was performed with STATA 15.0 software. Results: Five studies with 774 patients were included. The result indicated that patients with high PCI had a worse prognosis than those with low PCI. The combined hazard ratio was 2.79 [95%CI: (2.04, 3.82), p<0.001] for overall survival (OS) in patients with high PCI. Further subgroup analysis by the FIGO staging revealed that in stage III [HR: 2.61, 95%CI: (2.00, 3.40), p<0.001] and stage III-IV patients [HR: 2.69, 95%CI: (1.66, 4.36), p<0.001], a high PCI score was significantly associated with a worse prognosis. The PCI score had a greater impact on the OS of patients with higher stages. The combined hazard ratio was 1.89 [95%CI: (1.51, 2.36), p<0.001] for progression-free survival (PFS) in patients with high PCI. Conclusion: PCI may be used as a postoperative prognosis indicator in patients with advanced OC on primary debulking surgery. High PCI indicates a worse prognosis. However, further research is warranted to confirm these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
139. Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report.
- Author
-
Cosi, Donato Michele, Fragale, Cristina, Magri, Chiara, Carnevale, Aldo, Ciancetta, Antonella, Guidoboni, Massimo, Negrini, Massimo, Bronte, Giuseppe, and Calabrò, Luana
- Subjects
NON-small-cell lung carcinoma ,ERLOTINIB ,DASATINIB ,OSIMERTINIB ,PROTEIN-tyrosine kinase inhibitors ,ARACHNOID cysts ,CANCER patients ,GENETIC mutation - Abstract
Third-generation tyrosine kinase inhibitors are the first-line gold standard in treating advanced non-small-cell lung cancer bearing common EGFR mutations, but data documenting clinical efficacy in uncommon mutations are currently limited. In this paper, we describe the case of a patient bearing uncommon compound EGFR mutations in exon 20, who experienced a near-complete response to third-line Osimertinib, with metabolic complete response of pulmonary, nodal and ostheolytic lesions. This radiological assessment corresponded to an ECOG PS improvement (from three to one) and a substantial clinical benefit for the patients. Out of two mutations, S768I was associated with poor response to third-generation TKI and V774M had unknown clinical significance, highlighting the complexity of the correct management of these kinds of mutations. We reviewed the literature to document the up-to-date preclinical and clinical data concerning third-generation tyrosine kinase inhibitors for the treatment of patients bearing uncommon EGFR mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
140. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review.
- Author
-
Mahumud, Rashidul Alam, Shahjalal, Md., Dahal, Padam Kanta, Mosharaf, Md. Parvez, Hoque, Mohammad Enamul, and Wawryk, Olivia
- Subjects
RADIOTHERAPY complications ,RADIOTHERAPY ,HOSPITAL care ,ONLINE databases ,THERAPEUTIC complications ,KEYWORD searching ,HEALTH care reform - Abstract
Background: Hospitalisation resulting from complications of systemic therapy and radiotherapy places a substantial burden on the patient, society, and healthcare system. To formulate preventive strategies and enhance patient care, it is crucial to understand the connection between complications and the need for subsequent hospitalisation. This review aimed to assess the existing literature on complications related to systemic and radiotherapy treatments for cancer, and their impact on hospitalisation rates. Methods: Data was obtained via electronic searches of the PubMed, Scopus, Embase and Google Scholar online databases to select relevant peer-reviewed papers for studies published between January 1, 2000, and August 30, 2023. We searched for a combination of keywords in electronic databases and used a standard form to extract data from each article. The initial specific interest was to categorise the articles based on the aspects explored, especially complications due to systemic and radiotherapy and their impact on hospitalisation. The second interest was to examine the methodological quality of studies to accommodate the inherent heterogeneity. The study protocol was registered with PROSPERO (CRD42023462532). Findings: Of 3289 potential articles 25 were selected for inclusion with ~ 34 million patients. Among the selected articles 21 were cohort studies, three were randomised control trials (RCTs) and one study was cross-sectional design. Out of the 25 studies, 6 studies reported ≥ 10 complications, while 7 studies reported complications ranging from 6 to 10. Three studies reported on a single complication, 5 studies reported at least two complications but fewer than six, and 3 studies reported higher numbers of complications (≥ 15) compared with other selected studies. Among the reported complications, neutropenia, cardiac complications, vomiting, fever, and kidney/renal injury were the top-most. The severity of post-therapy complications varied depending on the type of therapy. Studies indicated that patients treated with combination therapy had a higher number of post-therapy complications across the selected studies. Twenty studies (80%) reported the overall rate of hospitalisation among patients. Seven studies revealed a hospitalisation rate of over 50% among cancer patients who had at least one complication. Furthermore, two studies reported a high hospitalisation rate (> 90%) attributed to therapy-repeated complications. Conclusion: The burden of post-therapy complications is emerging across treatment modalities. Combination therapy is particularly associated with a higher number of post-therapy complications. Ongoing research and treatment strategies are imperative for mitigating the complications of cancer therapies and treatment procedures. Concurrently, healthcare reforms and enhancement are essential to address the elevated hospitalisation rates resulting from treatment-related complications in cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
141. The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients' point of view.
- Author
-
Pomey, Marie-Pascale, Iliescu Nelea, Monica, Vialaron, Cécile, Normandin, Louise, Côté, Marie-Andrée, Desforges, Mado, Pomey-Carpentier, Pénélope, Adjtoutah, Nesrine, Fortin, Israël, Ganache, Isabelle, Régis, Catherine, Rosberger, Zeev, Charpentier, Danielle, Bélanger, Lynda, Dorval, Michel, Ghadiri, Djahanchah P., Lavoie-Tremblay, Mélanie, Boivin, Antoine, Pelletier, Jean-François, and Fernandez, Nicolas
- Subjects
PATIENTS' attitudes ,CANCER patients ,PATIENT experience ,BREAST cancer ,TELEPHONES - Abstract
Background: The PAROLE-Onco program was introduced in the province of Quebec, Canada in 2019. It integrates accompanying patients (APs), i.e., people who have been affected by cancer, into the clinical team as full members. These APs use their experiential knowledge with people undergoing treatment and with clinical teams. The aim of this paper is to evaluate, within the framework of two university medical centers, the perceptions of breast cancer patients who receive support from APs, particularly in terms of their active involvement in their care trajectory. Methods: A qualitative study based on semi-structured interviews with accompanied patients was performed. Fourteen individual interviews were conducted between July and September 2021 with women presenting different profiles in terms of age, education, professional status, type of treatment, family situation, and clinical background. The data were analyzed using thematic analysis, focusing on patients' perceptions of APs' contributions and suggested improvements for accessing AP support. Results: Three themes emerged from the semi-structured interviews: communication modalities used to connect patients with their APs, the characteristics of the support provided by APs, and the perceived effects of this support on the patients. Patients expressed a preference for telephone communication, highlighting its convenience and accessibility. The support provided by APs included emotional and informational support, neutrality, and adaptability. This relationship improved patient communication, reduced anxiety, helped regain control, and enhanced overall quality of life. The results emphasized the added value of APs in complementing the support offered by healthcare professionals. Patients noted the critical role of APs in helping them navigate the healthcare system, better understand their treatment processes, and manage their emotions. The ability of APs to provide practical advice and emotional reassurance was particularly valued. Overall, the findings underscored the significant impact of AP support on patients' experiences and highlighted areas for enhancing this service. Conclusion: This study highlights, during the care trajectory of people affected by breast cancer, APs' contribution to patients' emotional well-being because they improve, in particular, the management of emotions and communication with health professionals. Plain english summary: In 2019, we initiated the PAROLE-Onco program in Quebec, Canada, to support cancer patients by integrating Accompanying Patients (APs) into the medical team. These individuals, who have personally experienced cancer, join as full team members, sharing their insights with both patients and medical staff. Our study delved into the perceptions of breast cancer patients at two university hospitals regarding APs' involvement in their care trajectory. Through interviews with 14 women of diverse backgrounds and cancer experiences, we found that APs were instrumental in enhancing communication with doctors, facilitating the expression of challenging emotions, and aiding in treatment decisions. Patients valued the inclusion of APs in their care team and expressed gratitude for their support. Nonetheless, some encountered difficulties in reaching out to APs due to a lack of awareness or challenges involved in connecting. Overall, our research underscores the positive impact of involving APs in the care of breast cancer patients, and of enhancing emotional well-being and communication throughout the treatment journey. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
142. Effects of different exercise types and cycles on pain and quality of life in breast cancer patients: A systematic review and network meta-analysis.
- Author
-
Dong, Jin, Wang, Desheng, and Zhong, Shuai
- Subjects
EXERCISE physiology ,QUALITY of life ,BREAST cancer ,CANCER patients ,YOGIC therapy ,AEROBIC exercises ,RESISTANCE training - Abstract
Purpose: To determine the effect of different combinations of different exercise modalities with different training cycles on the improvement of quality of life and pain symptoms in breast cancer patients. Methods: The databases PubMed, Web of Science, Embase, and Scopus were searched through a computer network with a search deadline of 23 August 2023. Two researchers independently screened the literature, extracted data and performed methodological quality assessment of the included literature, and then performed the corresponding statistical analyses and graphing using stata17.0. Results: Thirty-six randomized control trial (RCT) studies involving 3003 participants and seven exercise modalities were included. Most of the exercise modalities improved patients' quality of life compared to usual care, with long-term aerobic combined with resistance exercise [SMD = 0.83,95% CI = 0.34,1.33,p = 0.001] and YOGA [SMD = 0.61,95% CI = 0.06,1.16,p = 0.029] treatments having a significant effect. For pain and fatigue-related outcome indicators, the treatment effect was not significant for all exercise modalities included in the analysis compared to the control group, but tended to be beneficial for patients. Conclusion: Long-term aerobic combined with resistance exercise was the most effective in improving quality of life and fatigue status in breast cancer patients, and aerobic exercise was more effective in improving pain symptoms in breast cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
143. Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland
- Author
-
Joanna Kufel-Grabowska, Maria Litwiniuk, and Mikołaj Bartoszkiewicz
- Subjects
medicine.medical_specialty ,Original Paper ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Influenza vaccine ,Cancer ,COVID-19 ,Influenza season ,medicine.disease ,vaccination ,Vaccination ,Seasonal influenza ,Oncology ,Family medicine ,Pandemic ,medicine ,Radiology, Nuclear Medicine and imaging ,business ,cancer patients ,influenza ,Healthcare system - Abstract
Introduction In the era of the COVID-19 pandemic overlapping with the influenza season, the number of infections with the abovementioned viruses may result in overload in the healthcare system, difficulties in the diagnosis of respiratory diseases, poorer access to appropriate therapy, and increased mortality. Aim of the study The aim of this study was to analyze the influence of the COVID-19 pandemic on the decision to be vaccinated against seasonal influenza in cancer patients. Material and methods An anonymous survey prepared by the authors was made available to patients at the Chemotherapy Department at the Greater Poland Cancer Center. The survey covered 236 respondents, both female (67.4%, n = 159) and male (32.6%, n =77). A 0-10 point numerical scale was used to assess the fear of coronavirus infection and the influenza. Data were collected from June 8 to September 30, 2020. The survey included 25 questions. The patients were informed by physicians about the voluntary and anonymous nature of the survey, to which they gave their oral consent. IBM SPSS Statistics 26 was used for the analysis. Results The vast majority of patients (69.5%, n = 164) have never been vaccinated against influenza and 30.5% (n = 72) have been vaccinated at least once in the past. In the face of the COVID-19 pandemic, almost ¼ of the patients (24.6%, n = 58) stated that they wanted to be vaccinated against influenza. Only 33.5% (n = 79) of the respondents believed that the influenza vaccine was effective. Conclusions Action is needed to increase the percentage of cancer patients who will be regularly vaccinated against the influenza. The COVID-19 pandemic may raise the interest of cancer patients in influenza vaccination.
- Published
- 2021
144. Paper-Based Survivorship Care Plans May be Less Helpful for Cancer Patients Who Search for Disease-Related Information on the Internet: Results of the Registrationsystem Oncological Gynecology (ROGY) Care Randomized Trial.
- Author
-
Nicolaije, Kim A. H., Ezendam, Nicole P. M., Pijnenborg, Johanna M. A., Boll, Dorry, Vos, Maria Caroline, Kruitwagen, Roy F. P. M., van de Poll-Franse, Lonneke V., Nicolaije, Kim Ah, Ezendam, Nicole Pm, Pijnenborg, Johanna Ma, and Kruitwagen, Roy Fpm
- Subjects
CANCER patients ,INTERNET in medicine ,CANCER treatment ,CANCER ,MEDICAL care use ,HEALTH behavior ,COMPUTER network resources ,COMMUNICATION ,COMPARATIVE studies ,FEMALE reproductive organ tumors ,INDUSTRIES ,INTERNET ,RESEARCH methodology ,MEDICAL cooperation ,MEDICAL informatics ,MEDICAL protocols ,RESEARCH ,SURVIVAL ,EVALUATION research ,RANDOMIZED controlled trials ,TUMOR treatment - Abstract
Background: The Institute of Medicine recommends Survivorship Care Plans (SCPs) for all cancer survivors. However, it is unclear whether certain patient groups may or may not benefit from SCPs.Objective: The aim was to assess whether the effects of an automatically generated paper SCP on patients' satisfaction with information provision and care, illness perceptions, and health care utilization were moderated by disease-related Internet use.Methods: Twelve hospitals were randomized to either SCP care or usual care in the pragmatic cluster randomized Registrationsystem Oncological GYnecology (ROGY) Care trial. Newly diagnosed endometrial cancer patients completed questionnaires after diagnosis (N=221; response: 74.7%, 221/296), 6 months (n=158), and 12 months (n=147), including patients' satisfaction with information provision and care, illness perceptions, health care utilization (how many times patients visited a medical specialist or primary care physician about their cancer in the past 6 months), and disease-related Internet use (whether patients used the Internet to look for information about cancer).Results: In total, 80 of 221 (36.2%) patients used the Internet to obtain disease-related information. Disease-related Internet use moderated the SCP care effect on the amount of information received about the disease (P=.03) and medical tests (P=.01), helpfulness of the information (P=.01), and how well patients understood their illness (P=.04). All stratified analyses were not statistically significant. However, it appeared that patients who did not seek disease-related information on the Internet in the SCP care arm reported receiving more information about their disease (mean 63.9, SD 20.1 vs mean 58.3, SD 23.7) and medical tests (mean 70.6, SD 23.5 vs mean 64.7, SD 24.9), finding the information more helpful (76.7, SD 22.9 vs mean 67.8, SD 27.2; scale 0-100), and understanding their illness better (mean 6.6, SD 3.0 vs mean 6.1, SD 3.2; scale 1-10) than patients in the usual care arm did. In addition, although all stratified analyses were not significant, patients who did seek disease-related information on the Internet in the SCP care arm appeared to receive less information about their disease (mean 65.7, SD 23.4 vs mean 67.1, SD 20.7) and medical tests (mean 72.4, SD 23.5 vs mean 75.3, SD 21.6), did not find the information more helpful (mean 78.6, SD 21.2 vs mean 76.0, SD 22.0), and reported less understanding of their illness (mean 6.3, SD 2.8 vs mean 7.1, SD 2.7) than patients in the usual care arm did.Conclusions: Paper SCPs appear to improve the amount of information received about the disease and medical tests, the helpfulness of the information, and understanding of the illness for patients who do not search for disease-related information on the Internet. In contrast, paper SCPs do not seem beneficial for patients who do seek disease-related information on the Internet.Trial Registration: ClinicalTrials.gov NCT01185626; https://clinicaltrials.gov/ct2/show/NCT01185626 (Archived by WebCite at http://www.webcitation.org/6fpaMXsDn). [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
145. Summaries of Papers.
- Subjects
DERMATOLOGY ,CANCER patients ,SKIN cancer ,CONNECTIVE tissues ,BASAL cell carcinoma ,HISTOLOGY - Abstract
The article presents the summaries of papers related to dermatology. One paper aims to record the presentation and treatment of basal cell carcinoma (BCC) by dermatologists in Great Britain. Evaluable records were obtained on 1597 BCC, median diameter 9mm, in 1366 patients during a two-week period. Another paper discusses outpatient surgery for sublingual exotoses. Histologically this condition is characterized by an outgrowth of trabecular bone with a cap of cartilage. Dermatologists often refer patients with this condition to orthopedic surgeons, where they are commonly treated as short stay inpatients.
- Published
- 1994
- Full Text
- View/download PDF
146. Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis.
- Author
-
Yu, Jerry, Kaur, Rajneesh, Ayeni, Femi Emmanuel, Eslick, Guy D., and Edirimanne, Senarath
- Subjects
THYROID cancer ,THYROTROPIN receptors ,CANCER patients ,CORONARY disease ,HEART disease related mortality ,CARDIOVASCULAR disease related mortality ,ATRIAL fibrillation ,LUTEINIZING hormone releasing hormone - Abstract
We performed a systematic review and meta-analysis of the literature regarding cardiovascular outcomes of differentiated thyroid cancer (DTC) patients who are on long term thyroid stimulating hormone suppression. Searches were carried out using Prisma guidelines in Medline, Embase, CENTRAL, CINAHL and Scopus databases. Eligible papers were those which investigated discrete cardiovascular clinical outcomes in TSH suppressed patients and meta-analysis of selected studies was performed using Revman 5.4.1. We found a total of 195 879 DTC patients with median length to follow up of 8.6 years (range 5–18.8 years). Analysis showed DTC patients to be at higher risk of atrial fibrillation (HR 1.58, 95% CI 1.40, 1.77), stroke (HR 1.14, 95% CI 1.09, 1.20) and all-cause mortality (HR 2.04, 95% CI 1.02, 4.07). However, there was no difference in risk of heart failure, ischemic heart disease or cardiovascular mortality. These findings suggest that degree of TSH suppression must be titrated to accommodate risk of cancer recurrence and cardiovascular morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
147. Experience, decision‐making and information needs around parenteral nutrition among people with advanced cancer, and their carers: A scoping review.
- Author
-
McCracken, Jennifer, Wheelwright, Sally, Hon, YiWen, and Shaw, Clare
- Subjects
CINAHL database ,CULTURE ,CAREGIVERS ,MEDICAL information storage & retrieval systems ,SYSTEMATIC reviews ,CANCER patients ,HEALTH literacy ,PATIENTS' attitudes ,FAMILY roles ,DECISION making ,QUALITY assurance ,DESCRIPTIVE statistics ,RESEARCH funding ,PARENTERAL feeding ,INFORMATION needs ,LITERATURE reviews ,MEDLINE - Abstract
Background: The present study aims to summarise current knowledge and identify gaps in knowledge and research regarding experience, decision‐making and information needs around parenteral nutrition, among people with advanced cancer, and their carers. Methods: This review was informed by previous methods and guidance on conducting and reporting scoping reviews. A literature search was conducted in March 2021 using Embase, Medline, CINAHL, Google and Web of Science to identify studies that examined the experience, decision‐making process and information needs of adults with advanced cancer, and their carers, who were making decisions around commencing and discontinuing parenteral nutrition. There were no date limitations, although only papers published in English were included. Results: Of the 588 papers identified, 12 papers, all qualitative, met the eligibility criteria. Despite the reported negative aspects of home parenteral nutrition, patients and carers felt the benefits outweighed these. There was variability in whether patients and carers felt involved in decisions around commencing parenteral nutrition. No studies specifically addressed information needs. Conclusions: Research is required to explore the information that patients with advanced cancer, and their carers, need to facilitate their decision‐making around commencing and discontinuing parenteral nutrition. We recommend the development of processes for obtaining written informed consent from patients commencing parenteral nutrition to ensure that core topics are discussed on initiation, enabling patients and carers to make informed decisions. Additionally, we recommend development of a national framework to inform patients and carers of the whole discharge process on PN from decision‐making to discontinuing PN. Key points: Carers would like to receive more information around home parenteral nutrition.No studies have specifically explored the information needs of patients with advanced cancer and their carers making decisions around parenteral nutrition.The best ways to communicate information around parenteral nutrition to patients and carers are unknown.Patients should be asked if they wish to involve a carer in decision‐making.Reasons for stopping parenteral nutrition are not routinely discussed with patients.The rationale for stopping parenteral nutrition should be discussed at its initiation.We recommend the development of procedures for obtaining written informed consent from patients commencing parenteral nutrition.We recommend the development of a national, standardised framework outlining the discharge process for patients with advanced cancer on home parenteral nutrition.Research is required to explore the information that patients with advanced cancer, and their carers, need to facilitate their decision‐making around commencing and discontinuing parenteral nutrition. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
148. Cancer and immigrants: Same care, different approach.
- Author
-
Saleem, Munazza and Khan, Zuhera
- Subjects
IMMIGRANTS ,CANCER treatment ,CANCER diagnosis ,EXPERIMENTAL design ,CANCER patients ,EMIGRATION & immigration - Abstract
Objective: To examine the psychosocial issues that emerge in the patients and their spouses upon cancer diagnosis and during its treatment. Furthermore, to search the immigrant specific supportive approaches when providing cancer care. Study Design: Systematic Literature Review. Period: 2008 to 2020. Material & Methods: Thirty-three articles, which met the pre-set criteria, were analyzed, and employed as a reference in this paper. Results: The analysis of the literature reported that depression, anxiety and low quality of life are prevalent among cancer patients and their spouses. The well-established evidence strengthened that culturally competent care, social, as well as linguistic support, are the immigrant tailored strategies that can help satisfy the need of this vulnerable population. Conclusion: The key research findings presented in the paper concludes that immigrants experiencing cancer and their spouses are more prone to acquire psychosocial issues due to their unprecedented circumstances that demand specific immigrants' tailored approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
149. Challenges to Pain Medicine Management at Home: Commentary on the Schumacher et al. Papers.
- Author
-
Hopkinson, Jane B.
- Subjects
- *
PAIN management , *HOME care services , *ANALGESICS , *SCHOOL psychology methodology , *CANCER patients , *RANDOMIZED controlled trials - Published
- 2014
- Full Text
- View/download PDF
150. Real world safety of bevacizumab in cancer patients: A systematic literature review of case reports.
- Author
-
Dang, Amit, Jagan Mohan Venkateswara Rao, P., Kishore, Ravi, and Vallish, B.N.
- Subjects
DRUG efficacy ,ONLINE information services ,RESPIRATORY organs ,CLINICAL drug trials ,BRAIN diseases ,FISTULA ,SYSTEMATIC reviews ,CANCER patients ,CARDIOVASCULAR system ,DIGESTIVE organs ,TUMORS ,BEVACIZUMAB ,MEDLINE ,INTESTINAL perforation ,PATIENT safety ,EVALUATION - Abstract
BACKGROUND: Real-world safety of bevacizumab in cancer patients is limited. OBJECTIVE: To review the adverse drug reactions (ADRs) due to bevacizumab in cancer patients, in published case reports. METHODS: PubMed was searched; case reports of patients with any type of cancer, administered with bevacizumab (monotherapy/combination) and reported ADRs were included. Causality of ADRs was presented as reported in individual papers. ADRs were classified using the information in the USFDA-approved prescribing information (PI) of bevacizumab as 'Serious', 'Common', and 'Post-marketing surveillance' ADRs; ADRs not mentioned in the bevacizumab PI were termed as 'Non-label ADRs'. RESULTS: A total of 130 published papers comprising 154 cases from 22 different countries were included. Most papers (102/130; 78.46%) had moderate methodological quality. Age range of patients was 9-77 years. Off-label use of bevacizumab was found in 34/154 cases (22.08%). Ninety-six unique ADRs were found among 154 ADRs; most reported ADRs affected circulatory, digestive, and respiratory systems (33, 32, and 26 cases respectively). Most commonly reported ADRs were posterior leukoencephalopathy, fistulae, and gastrointestinal perforation (17, 17, and 16 cases respectively). Twenty-eight unique non-label ADRs (29.17%) were found. CONCLUSION: Bevacizumab is associated with more ADRs in the real world among cancer patients than those reported during clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.